GSA Capital Partners’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-10,348
| Closed | -$100K | – | 2018 |
|
|
2025
Q3 | $100K | Sell |
10,348
-216,234
| -95% | -$1.91M | 0.01% | 1525 |
|
|
2025
Q2 | $1.86M | Buy |
226,582
+95,253
| +73% | +$797K | 0.13% | 147 |
|
|
2025
Q1 | $939K | Buy |
131,329
+114,043
| +660% | +$848K | 0.08% | 379 |
|
|
2024
Q4 | $134K | Buy |
+17,286
| New | +$162K | 0.01% | 1488 |
|
|
2024
Q3 | – | Sell |
-151,753
| Closed | -$1.78M | – | 1946 |
|
|
2024
Q2 | $1.78M | Buy |
+151,753
| New | +$2.36M | 0.12% | 196 |
|
|
2023
Q4 | – | Sell |
-37,668
| Closed | -$620K | – | 1853 |
|
|
2023
Q3 | $620K | Buy |
+37,668
| New | +$683K | 0.05% | 665 |
|
|
2022
Q2 | – | Sell |
-10,970
| Closed | -$364K | – | 1734 |
|
|
2022
Q1 | $364K | Buy |
+10,970
| New | +$305K | 0.05% | 753 |
|
|
2021
Q4 | – | Sell |
-6,825
| Closed | -$286K | – | 1736 |
|
|
2021
Q3 | $286K | Buy |
+6,825
| New | +$246K | 0.03% | 1055 |
|
|
2020
Q1 | – | Sell |
-22,034
| Closed | -$903K | – | 1473 |
|
|
2019
Q4 | $903K | Buy |
+22,034
| New | +$870K | 0.11% | 260 |
|
|
2019
Q2 | – | Sell |
-17,966
| Closed | -$1.03M | – | 1689 |
|
|
2019
Q1 | $1.03M | Buy |
17,966
+866
| +5% | +$42.9K | 0.1% | 277 |
|
|
2018
Q4 | $717K | Hold |
17,100
| – | – | 0.08% | 369 |
|
|
2018
Q3 | $1.29M | Sell |
17,100
-788
| -4% | -$56.8K | 0.07% | 506 |
|
|
2018
Q2 | $1.28M | Buy |
+17,888
| New | +$854K | 0.06% | 580 |
|
|
2016
Q2 | – | Sell |
-15,100
| Closed | -$163K | – | 1876 |
|
|
2016
Q1 | $163K | Buy |
+15,100
| New | +$193K | 0.01% | 1532 |
|
Other funds holding RGNX
RG
IHAM
